Patent Assignment
Reel/Frame 060759/0665
Assignment of Assignor's Interest
Recorded: 2022-08-09
Pages: 12
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2012-12-05
Assignee
TEKMIRA PHARMACEUTICALS CORPORATION
100 - 8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Methods of Delivering Oligonucleotides to Immune Cells
Application:
17/244,445 →
Publication:
US 2022/0079970
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 23, 2022
From: NOVOBRANTSEVA, TATIANA; AKINC, AKIN; SUGO, TSUKASA
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 059983/0009 →
Change of Name
Aug 26, 2022
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 060908/0852 →
Merger
Sep 9, 2022
From: PROTIVA BIOTHERAPEUTICS, INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 061406/0499 →